Microsoft Stock: Technically Compelling, Too Rich For Me
Microsoft posts record numbers and the stock reclaims its 200-day line. Still, there's an elephant in the room for me that turns the valuation into a risk. Why I'm not buying.
Astera Labs: Up 342% in One Quarter. Here's Why I'm Still Not Buying.
Five customers generate 90% of revenue, and the P/E sits above 90 based on 2028 estimates. The best NASDAQ-100 stock of recent months has a profile few people question. I did.
